Blood–Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Blood–Brain Barrier Permeation and Efflux Exclusion of Anticholinergics Used in the Treatment of Overactive Bladder
Authors
Keywords
-
Journal
DRUGS & AGING
Volume 29, Issue 4, Pages 259-273
Publisher
Springer Nature
Online
2012-03-07
DOI
10.2165/11597530-000000000-00000
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Impact of the Cognitive Status on the Memory Complaints in MS Patients
- (2016) M. Demers et al. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES
- A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder
- (2011) Ernesto Callegari et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Prevalence and Predictors of “Subjective Cognitive Complaints” in the Sydney Memory and Ageing Study
- (2010) Melissa J. Slavin et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder
- (2010) D. Staskin et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Blood–brain barrier disruption and enhanced vascular permeability in the multiple sclerosis model EAE
- (2010) Jami Bennett et al. JOURNAL OF NEUROIMMUNOLOGY
- The Role of P-Glycoprotein in Limiting Brain Penetration of the Peripherally Acting Anticholinergic Overactive Bladder Drug Trospium Chloride
- (2009) J. Geyer et al. DRUG METABOLISM AND DISPOSITION
- Exploratory pilot study assessing the risk of cognitive impairment or sedation in the elderly following single doses of solifenacin 10 mg
- (2009) Keith A Wesnes et al. Expert Opinion On Drug Safety
- Contraindicated medication use among patients in a memory disorders clinic
- (2008) Cynthia Barton et al. American Journal Geriatric Pharmacotherapy
- Pharmacological characterization of a novel investigational antimuscarinic drug, fesoterodine, in vitro and in vivo
- (2008) Peter Ney et al. BJU INTERNATIONAL
- PDE5 inhibitors enhance tumor permeability and efficacy of chemotherapy in a rat brain tumor model
- (2008) Keith L. Black et al. BRAIN RESEARCH
- The Effects of Antimuscarinic Treatments in Overactive Bladder: An Update of a Systematic Review and Meta-Analysis
- (2008) Christopher R. Chapple et al. EUROPEAN UROLOGY
- In Vivo Quantitative Autoradiographic Analysis of Brain Muscarinic Receptor Occupancy by Antimuscarinic Agents for Overactive Bladder Treatment
- (2008) S. Maruyama et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Tolterodine does not affect memory assessed by passive-avoidance response test in mice
- (2007) Gregg D. Cappon et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Blood–brain barrier: Ageing and microvascular disease – systematic review and meta-analysis
- (2007) Andrew J. Farrall et al. NEUROBIOLOGY OF AGING
- The effects of anticholinergic drugs on attention span and short-term memory skills in children
- (2007) Karla M. Giramonti et al. NEUROUROLOGY AND URODYNAMICS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started